CS Diagnostics Corp. (CSDX)

Market Cap	2.75M -96.6%
Revenue (ttm)	204.00K +83.9%
Net Income	71.22K +9,258.6%
EPS	0.00 +5,580.0%
Shares Out	249.99M
PE Ratio	38.73
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,300
Open	0.0110
Previous Close	0.0061
Day's Range	0.0110 - 0.0110
52-Week Range	0.0004 - 0.4000
Beta	-22.80
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About CS Diagnostics

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, Wyoming.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSDX

Financial Performance

In 2025, CS Diagnostics's revenue was $204,000, an increase of 83.93% compared to the previous year's $110,911. Earnings were $71,219, an increase of 9258.61%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error